Business

February 5, 2014 9:24 AM

GSK’s China drug sales continue falling in bribery scandal fallout

GlaxoSmithKline’s drug sales continued falling in China amid the fallout from a bribery scandal in that country, but global sales made up for the Chinese setback and contributed to GSK’s overall sales growth in the fourth quarter.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs